🔓 Unlock the full profile of Ismael Hidalgo (Pharmaron), including verified contact details, financial insights, and professional associations.
See Ismael Hidalgo Full ProfileBelow are the ✅ Verified Contact Details to help you connect directly:
Email: ism*****@pha******.com
Mobile: 83952*****
Estimated Net Worth 💰 : ₹0 – ₹500+ Cr (approx. $0 – $60M)
Key Insights You Should Know About This Individual
- Ismael Hidalgo is a co-founder and serves as the Chief Scientist at Absorption Systems, a company that specializes in drug development and testing services.
- Under Ismael Hidalgo's leadership, Absorption Systems has contributed significantly to the formulation and safety assessment of pharmaceutical products.
- The company, founded in 1997, has established a strong reputation for its innovative approach and advanced scientific methodologies in the biotech industry.
- Prior to co-founding Absorption Systems, Ismael Hidalgo held the position of Senior Investigator at SmithKline Beecham, where critical research contributions were made.
- Ismael Hidalgo's background includes working as a Sr. Research Investigator at GlaxoSmithKline, bringing valuable experience to the founding of Absorption Systems.
- Pharmaron, the current organization associated with Ismael Hidalgo, is a globally recognized firm in the pharmaceutical research and development sector, founded in 2004.
- Pharmaron focuses on preclinical research and development, drug discovery, and manufacturing, emphasizing its commitment to enhancing drug development processes.
- The organization is publicly traded on the Shenzhen Stock Exchange under the symbol 300759, indicating its substantial growth and trust within the industry.
- Ismael Hidalgo’s tenure has been marked by scientific excellence and an unwavering commitment to advancing pharmaceutical science, positioning both the individual and the organization at the forefront of the industry.
- Through driving innovative solutions and maintaining high standards, Ismael Hidalgo has significantly impacted the landscape of drug development and safety evaluation.